Workflow
自锁托槽
icon
Search documents
最新!口腔医疗科技公司获战略投资
思宇MedTech· 2025-07-11 07:57
2025年7月10日, 杭州舒雅齐医学科技有限公司 宣布完成来自 时代天使集团 的战略投资。此次交易完成 后, 时代天使将持有舒雅齐35%的股份 ,汉斯夫(杭州)医学科技有限公司继续 持有65%的股份 。双方表 示,将在保持品牌独立运营的基础上,实现资源协同,共同探索创新合作模式。 此次战略投资的具体金额未披露。根据公开信息,双方合作的重点在于 强化舒雅齐的医学服务能力,提升其 在新兴市场的服务覆盖与技术支持能力 。 # 关于 舒雅齐 公司产品线包括 "经典版"和"星空版"隐形矫治器 ,分别适用于不同类型的牙齿畸形病例。舒雅齐的产品主要 应用于青少年及成人轻中度牙齿错颌畸形矫治,已在多个新兴市场区域实现规模化应用。 思宇年度活动回顾: 首届全球眼科大会 | 首届全球骨科大会 | 首届全球心血管大会 | 首届全球医美科技大会 即将召开: 2025年7月17日,第二届全球医疗科技大会 杭州舒雅齐医学科技有限公司 成立于2025年4月30日,总部位于浙江省杭州市余杭区,是一家专注于口腔正 畸服务的医疗科技公司。公司主营业务涵盖 正畸类口腔医疗器械 产品的研发、生产和销售,致力于为牙医提 供数字化、高性价比的隐形矫治 ...
隐形正畸市场格局生变:时代天使收购舒雅齐35%股权背后的攻守之道
Xin Lang Zheng Quan· 2025-06-27 07:10
Core Insights - The acquisition of a 35% stake in Hangzhou Shuyaqi Medical Technology by Times Angel signifies a strategic move to enhance market positioning amid increasing competition in the orthodontic industry [1][4] - This transaction reflects a broader trend of industry consolidation and the evolution of competitive dynamics within the orthodontic market [4][5] Group 1: Strategic Positioning - The acquisition is not merely a financial maneuver but a strategic positioning to enhance business synergy, market defense, and international expansion [2][3] - Times Angel aims to complement its product line by integrating Shuyaqi's offerings, which include a comprehensive range of orthodontic solutions and digital equipment [2][3] - The pricing strategy of Shuyaqi's products, which are significantly lower than Times Angel's, allows for a dual-brand strategy that targets both high-end and mid-range markets [2][3] Group 2: Market Dynamics - The competitive landscape is shifting, with Times Angel maintaining a leading position in the Chinese market but experiencing a slowdown in growth, with a 3.2% year-on-year increase in case numbers [3][4] - The acquisition serves as a defensive strategy against potential competition from Hanseph's "Aorishi" brand, which has introduced similar orthodontic products [3][4] - The international market is also a focus, with Times Angel's international case numbers reaching 140,000 in 2024, representing 39% of total cases, indicating a significant global presence [3][4] Group 3: Industry Evolution - The acquisition is expected to accelerate the integration process within the orthodontic market, potentially leading to increased merger and acquisition activity [4][5] - The competition is evolving from a focus on individual product performance to a comprehensive ecosystem that includes devices, materials, and software [5][6] - The selection of Shuyaqi, a newly established company, by a market leader highlights the importance of technological innovation and integration within the industry [5][6]